Cite
MLA Citation
Edward V. Loftus et al.. “S770 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn's Disease: IBDQ in the SEAVUE Study.” American journal of gastroenterology, vol. 116, n.d., pp. S355–S357. http://access.bl.uk/ark:/81055/vdc_100144523340.0x000023